Investment Rating - The industry investment rating is "Positive" [8] Core Insights - Ruby oil (Calanus oil) is gaining attention in the health supplement industry due to its rich content of beneficial components such as polyunsaturated fatty acids and astaxanthin, which possess anti-inflammatory properties. The total market size for the fish oil sector in China is projected to reach approximately 5.6 billion yuan in 2024, with a CAGR of 10% from 2010 to 2024. The demand is driven by both the aging population and a growing trend among younger consumers seeking anti-inflammatory benefits [2][5][19]. Summary by Sections Ruby Oil Overview - Ruby oil is exclusively produced by the Norwegian company Zooca Calanus and is derived from Calanus finmarchicus, a type of copepod found in non-industrial waters of Norway. Its composition includes 38% polyunsaturated fatty acids, 15% monounsaturated fatty acids, 24% polyunsaturated fatty acids, 16% saturated fatty acids, and 2% astaxanthin. The oil is primarily targeted at oral anti-inflammatory and anti-aging markets, particularly within the broader fish oil market [4][16]. Market Trends - The demand for anti-inflammatory products is increasing across all age groups. The market for oral anti-inflammatory and anti-aging products in China reached 57.4 billion yuan in 2023, with a CAGR of 18% from 2016 to 2023. The fish oil and omega-3 products market is expected to grow to 5.6 billion yuan by 2024, with a CAGR of 10% from 2010 to 2024 [5][19]. Product Distribution and Target Demographics - Ruby oil products are primarily sold through cross-border e-commerce platforms, focusing on female consumers. Major brands utilizing ruby oil include VitaOcean, Feicui, and SuperSmart, with prices ranging from 328 yuan to 502 yuan for 60 capsules. Marketing strategies are increasingly targeting younger demographics, despite the traditional focus on older consumers [6][23].